GALNT1/13 as Novel Mediators of Pulmonary Arterial Hypertension

被引：0
|
作者：
Shi, Y. [1 ]
Zagorski, J. [1 ]
Gupta, A. [2 ]
Sun, X. [2 ]
Gupta, G. [3 ]
Machado, R. F. [4 ]
Garcia, J. G. [5 ]
Tang, H. [2 ]
Desai, A. A. [6 ]
机构：
[1] Indiana Univ, Dept Med, Indianapolis, IN USA
[2] Univ Arizona, Med, Tucson, AZ USA
[3] Univ Arizona, Ctr Canc, Dept Otolaryngol, Tucson, AZ USA
[4] Indiana Univ, Div Pulm Crit Care Sleep & Occupat Med, Indianapolis, IN 46204 USA
[5] Univ Arizona, Tucson, AZ USA
[6] Indiana Univ, Med Cardiol, Indianapolis, IN 46204 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3660
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Novel approaches to the pharmacotherapy of pulmonary arterial hypertension
    Olsson, Karen M.
    Hoeper, Marius M.
    DRUG DISCOVERY TODAY, 2009, 14 (5-6) : 284 - 290
  • [32] Novel Pharmacological Targets for Pulmonary Arterial Hypertension
    Klinger, James R.
    COMPREHENSIVE PHYSIOLOGY, 2021, 11 (04) : 2297 - 2349
  • [33] A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension
    Grinnan, Daniel
    Farkas, Laszlo
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (12) : 1460 - 1461
  • [34] NOVEL BIOMARKERS IN IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
    Rhodes, C. J.
    Wharton, J.
    Howard, L. S.
    Gibbs, J. S. R.
    Wilkins, M. R.
    THORAX, 2010, 65 : A44 - A44
  • [35] Novel serum biomarkers in pulmonary arterial hypertension
    McGlinchey, Neil
    Johnson, Martin K.
    BIOMARKERS IN MEDICINE, 2014, 8 (08) : 1001 - 1011
  • [36] Novel concepts in the pathobiology of pulmonary arterial hypertension
    Rosenkranz, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (40) : S167 - S169
  • [37] Novel strategies for treatment of pulmonary arterial hypertension
    Jasinska-Stroschein, Magdalena
    Orszulak-Michalak, Daria
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2017, 71 : 577 - 588
  • [38] Ranolazine as a novel therapy for pulmonary arterial hypertension
    Gong, Mengqi
    Fragakis, Nikolaos
    Zhang, Chengzong
    Zhang, Zhiwei
    Li, Guangping
    Liu, Tong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 860 - 862
  • [39] Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with BMPR2 mutation
    Vengethasamy, Leanda
    Quarck, Rozenn
    Delcroix, Marion
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [40] GPCRs in Pulmonary Arterial Smooth Muscle Cells as Novel Targets in Pulmonary Arterial Hypertension
    Gorr, Matthew W.
    Sriram, Krishna
    Insel, Paul A.
    FASEB JOURNAL, 2017, 31
12345